Recent Finacing
Recent Raise
Amakem develops ophthalmology therapeutics using a proprietary 'Localized Drug Action' platform, advancing ROCK inhibitor lead AMA0076 for glaucoma toward clinical proof-of-concept from its BioVille, University of Hasselt base.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
